French pharma firm Cooper seeks debt for Charterhouse LBO
Coopération Pharmaceutique Française, the French pharmaceuticals distributor known as Cooper, has bank meetings scheduled on Wednesday for more than €350m of new debt for its leveraged buyout by Charterhouse.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: